Stock 600535 TASLY PHARMACEUTICAL GROUP CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Tasly Pharmaceutical Group Co., Ltd

Equities

600535

CNE000001C81

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-18 pm EDT 		5-day change 1st Jan Change
15.33 CNY -0.58% Intraday chart for Tasly Pharmaceutical Group Co., Ltd -0.58% -9.93%
Apr. 16 Tasly Pharmaceutical Group Returns to Profit in 2023 as Operating Income Stays Flat MT
Apr. 15 Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Tasly Pharmaceutical Group Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The Company's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The Company mainly distributes its products in the domestic market.

Number of employees: 9,223

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chinese Medicines
68.8 %
5,557 64.7 % 5,971 68.8 % +7.46%
Pharmaceutical Business
14.0 %
1,417 16.5 % 1,215 14.0 % -14.21%
Chemical Pharmaceuticals
13.9 %
1,270 14.8 % 1,203 13.9 % -5.30%
Biological Drugs
2.2 %
248 2.9 % 190 2.2 % -23.47%
Chemical Raw Materials
0.7 %
71 0.8 % 57 0.7 % -19.67%
Other Business
0.4 %
31 0.4 % 38 0.4 % +22.38%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.7 %
8,593 100.0 % 8,635 99.7 % +0.49%
Overseas
0.3 %
-- 23 0.3 % -

Managers

Managers TitleAgeSince
Jing Su CEO
 Chief Executive Officer 61 18-04-15
Jie Wei DFI
 Director of Finance/CFO 47 18-07-08
Ying Zhao IRC
 Investor Relations Contact - -
Jie Yu SEC
 Corporate Secretary 49 17-03-30

Members of the board

Members of the board TitleAgeSince
Xiao Meng Jiang BRD
 Director/Board Member 60 07-08-16
Nai Feng Wu BRD
 Director/Board Member 72 05-09-08
Kai Jing Yan CHM
 Chairman 45 14-03-27
He Sun BRD
 Director/Board Member 65 15-04-26
Zheng Liang Ye CHM
 Chairman 57 18-04-15
Ai Chun Ju BRD
 Director/Board Member 51 14-04-13
Jing Su CEO
 Chief Executive Officer 61 18-04-15
Liu Xin BRD
 Director/Board Member 56 18-04-15
Bin Zhang BRD
 Director/Board Member 70 21-06-01
Shunnan Zhang BRD
 Director/Board Member 51 18-04-15

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,499,700,130 736,727,818 ( 49.13 %) 5,750,125 ( 0.3834 %) 49.13 %

Shareholders

NameEquities%Valuation
Kai Jing Yan
48.35 %
725,160,596 48.35 % 1 616 M ¥
Shao Luan Liu
0.8946 %
13,416,705 0.8946 % 30 M ¥
Fullgoal Fund Management Co., Ltd.
0.6375 %
9,559,930 0.6375 % 21 M ¥
China Southern Asset Management Co., Ltd.
0.6187 %
9,277,964 0.6187 % 21 M ¥
Wen Hua Liu
0.6063 %
9,092,366 0.6063 % 20 M ¥
Wei Yang
0.5757 %
8,633,440 0.5757 % 19 M ¥
Yinhua Fund Management Co., Ltd.
0.5305 %
7,956,106 0.5305 % 18 M ¥
Tianijn Shunqi Technology Development Partnership LP
0.4836 %
7,252,158 0.4836 % 16 M ¥
Bosera Asset Management Co., Ltd.
0.4704 %
7,055,110 0.4704 % 16 M ¥
Tianjin Shanzhen Technology Development Partnership LP
0.4308 %
6,460,255 0.4308 % 14 M ¥

Holdings

NameEquities%Valuation
IMMUNOTECH BIOPHARM LTD
18.87%
 97,102,571 18.87% 46,278,114 $

Company contact information

Tasly Pharmaceutical Group Co., Ltd.

2, Puji River East Road Beichen District

300410, Tianjin

+86 22 2673 6999

http://www.tasly.com
address Tasly Pharmaceutical Group Co., Ltd(600535)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Alternative Medicine

Sales per Business

Sales per region

Ratings for Tasly Pharmaceutical Group Co., Ltd

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
15.33 CNY
Average target price
13.88 CNY
Spread / Average Target
-9.49%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-9.93% 3.15B
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+40.86% 6.18B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-16.30% 4.46B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
-1.58% 3.01B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-1.70% 2.55B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+37.23% 1.83B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-12.78% 1.59B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+1.02% 1.66B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-12.97% 1.53B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+36.02% 1.4B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 600535 Stock
  4. Company Tasly Pharmaceutical Group Co., Ltd